Administration Core
行政核心
基本信息
- 批准号:8920511
- 负责人:
- 金额:$ 3.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Administrative Core A plays an essential role in administering, coordinating, and maintaining the integration and cohesion of this Program as the Project Leaders come from different departments of the Medical School. This Core supports the efforts of the Director, Dr. Chu, and Co-Director, Dr. Cheng, of the Core to oversee and direct the administration and management of this Program and to provide the scientific leadership that ensures the appropriate focus of the Project Leaders and essential scientific interactions.
Moreover, this Core will ensure proper coordination of the individual Projects. This Core will provide the appropriate administrative services as well as financial oversight and management to support the Program and the individual Project Leaders. A major function supported by this Core is secretarial assistance to prepare progress reports, continuation reports, and renewals and to organize the Project Leaders monthly meetings. Once the External Advisory Board is constituted, this Core will organize the annual EAB meeting as well as organize the annual retreat.
Thus, Core A is a critically important element to allow the Program to function as an efficient and cohesive unit. In addition, Core A will play a key role in ensuring the timely communication and dissemination of results in publications and highlight the progress of the research in various meetings and conferences.
行政核心A在管理,协调和维护该计划的整合和凝聚力方面发挥着至关重要的作用,因为项目负责人来自医学院的不同部门。该核心支持核心主任朱博士和联合主任郑博士监督和指导本计划的行政和管理,并提供科学领导,确保项目负责人的适当重点和必要的科学互动。
此外,这一核心将确保各个项目的适当协调。该核心将提供适当的行政服务以及财务监督和管理,以支持计划和各个项目负责人。该核心支助的一项主要职能是秘书处协助编写进度报告、延续报告和续会报告,并组织项目负责人每月会议。一旦外部咨询委员会成立,该核心将组织年度EAB会议以及组织年度务虚会。
因此,核心A是一个至关重要的因素,使该计划能够作为一个有效和有凝聚力的单位发挥作用。此外,核心A将发挥关键作用,确保及时交流和传播出版物中的成果,并在各种会议和大会上突出介绍研究进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YUNG-CHI CHENG其他文献
YUNG-CHI CHENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YUNG-CHI CHENG', 18)}}的其他基金
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
8175586 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Characterization of Predictive Biomarkers for the Clinical Efficacy of PHY906
PHY906 临床疗效的预测生物标志物的表征
- 批准号:
8920509 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
8528511 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Characterization of Predictive Biomarkers for the Clinical Efficacy of PHY906
PHY906 临床疗效的预测生物标志物的表征
- 批准号:
8555271 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
8727468 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
9146289 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
8333321 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
中草药作为癌症化疗的新范例
- 批准号:
8920507 - 财政年份:2011
- 资助金额:
$ 3.69万 - 项目类别:
相似海外基金
Traditional Chinese Herbs as Probes of P2X Receptors and other Ion Channels in the Pain Pathway
中药作为 P2X 受体和疼痛通路中其他离子通道的探针
- 批准号:
410816690 - 财政年份:2019
- 资助金额:
$ 3.69万 - 项目类别:
Research Grants
Reconstructing tooth early stage using human cells and screening the potential Chinese herbs for tissue-regeneration
利用人体细胞重建牙齿早期并筛选潜在的组织再生中药
- 批准号:
21890267 - 财政年份:2009
- 资助金额:
$ 3.69万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Project 3 - Modulation of Autoimmune Arthritis by Chinese Herbs
项目3 - 中药调节自身免疫性关节炎
- 批准号:
7051083 - 财政年份:2005
- 资助金额:
$ 3.69万 - 项目类别:
Project 1 - Dose Escalation Study of Chinese Herbs in Osteoathritis of the Knee
项目1 - 中药治疗膝骨关节炎的剂量递增研究
- 批准号:
7051081 - 财政年份:2005
- 资助金额:
$ 3.69万 - 项目类别:
CHINESE HERBS--AN ALTERNATIVE TREATMENT FOR HOT FLASHES
中药——潮热的替代疗法
- 批准号:
2284612 - 财政年份:1994
- 资助金额:
$ 3.69万 - 项目类别:
CHINESE HERBS--AN ALTERNATIVE TREATMENT FOR HOT FLASHES
中药——潮热的替代疗法
- 批准号:
2284611 - 财政年份:1994
- 资助金额:
$ 3.69万 - 项目类别:
INORGANIC AND PHOTOLYTIC DEGRADATION GLC. MEDICINAL INGREDIENTS IN CHINESE HERBS
无机和光解降解 GLC。
- 批准号:
7245069 - 财政年份:1972
- 资助金额:
$ 3.69万 - 项目类别:
Project 1 - Dose Escalation Study of Chinese Herbs in Osteoathritis of the Knee
项目1 - 中药治疗膝骨关节炎的剂量递增研究
- 批准号:
7549313 - 财政年份:
- 资助金额:
$ 3.69万 - 项目类别:
Project 1 - Dose Escalation Study of Chinese Herbs in Osteoathritis of the Knee
项目1 - 中药治疗膝骨关节炎的剂量递增研究
- 批准号:
7549307 - 财政年份:
- 资助金额:
$ 3.69万 - 项目类别:
Project 3 - Modulation of Autoimmune Arthritis by Chinese Herbs
项目3 - 中药调节自身免疫性关节炎
- 批准号:
7678981 - 财政年份:
- 资助金额:
$ 3.69万 - 项目类别: